AAAAAA
Results:
1-7
|
Results: 7
Authors:
PARCHMENT RE
GORDON M
GRIESHABER CK
SESSA C
VOLPE D
GHIELMINI M
Citation: Re. Parchment et al., PREDICTING HEMATOLOGICAL TOXICITY (MYELOSUPPRESSION) OF CYTOTOXIC DRUG-THERAPY FROM IN-VITRO TESTS, Annals of oncology, 9(4), 1998, pp. 357-364
Authors:
PARCHMENT RE
TOMASZEWSKI JE
GRIESHABER CK
VALERIOTE FA
CORBETT TH
LORUSSO PM
Citation: Re. Parchment et al., IN-VITRO HEMATOTOXICOLOGY STUDIES OF NEUTROPENIA INDUCED BY THE NOVELAGENT XK469, Annals of oncology, 9, 1998, pp. 205-205
Authors:
LORUSSO PM
FOSTER B
WOZNIAK A
FLAHERTY L
SHIELDS A
ZALUPSKI M
KOCAREK T
GRIESHABER CK
PARCHMENT RE
Citation: Pm. Lorusso et al., PHASE-I CLINICAL-TRIAL OF KRN5500, Annals of oncology, 9, 1998, pp. 474-474
Authors:
VOLPE DA
TOMASZEWSKI JE
PARCHMENT RE
GARG A
FLORA KP
MURPHY MJ
GRIESHABER CK
Citation: Da. Volpe et al., MYELOTOXIC EFFECTS OF THE BIFUNCTIONAL ALKYLATING AGENT BIZELESIN ON HUMAN, CANINE AND MURINE MYELOID PROGENITOR CELLS, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 143-149
Authors:
PARCHMENT RE
VOLPE DA
LORUSSO PM
ERICKSONMILLER CL
MURPHY MJ
GRIESHABER CK
Citation: Re. Parchment et al., IN-VIVO-IN-VITRO CORRELATION OF MYELOTOXICITY OF 9-METHOXYPYRAZOLOACRIDINE (NSC-366140, PD115934) TO MYELOID AND ERYTHROID HEMATOPOIETIC PROGENITORS FROM HUMAN, MURINE, AND CANINE MARROW, Journal of the National Cancer Institute, 86(4), 1994, pp. 273-280
Authors:
VOLPE DA
DU DL
GRIESHABER CK
MURPHY MJ
Citation: Da. Volpe et al., IN-VITRO CHARACTERIZATION OF THE MYELOTOXICITY OF CYCLOPENTENYL CYTOSINE (VOL 34, PG 103, 1994), Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 182-182
Authors:
VOLPE DA
DU DL
GRIESHABER CK
MURPHY MJ
Citation: Da. Volpe et al., IN-VITRO CHARACTERIZATION OF THE MYELOTOXICITY OF CYCLOPENTENYL CYTOSINE, Cancer chemotherapy and pharmacology, 34(2), 1994, pp. 103-108
Risultati:
1-7
|